Platelet-Rich Plasma Clinical Trials 2023

Browse 6 Platelet Rich Plasma Medical Studies Across 8 Cities
9 Platelet Rich Plasma Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Platelet-Rich Plasma Clinical Trials 2023

Reviewed by Michael Gill, B. Sc.

Image of St. Elizabeth Healthcare Edgewood in Edgewood, United States.

6 Platelet Rich Plasma Clinical Trials Near Me

Top Cities for Platelet Rich Plasma Clinical Trials

Madison

2Active Trials

Wisconsin Institute of Medical ResearchTop Active Site

Edgewood

1Active Trials

St. Elizabeth Healthcare EdgewoodTop Active Site

Platelet-rich Plasma Clinical Trials by Phase of Trial

N/A Platelet-rich Plasma Clinical Trials

3Active Platelet-rich Plasma Clinical Trials

3Number of Unique Treatments

1Number of Active Locations

Xenograft and PRP PRP - platelet rich plasma injection Hiatal Hernia Repair with Platelet Rich Plasma

Most Recent Platelet Rich Plasma Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

Xenograft and PRP for Non Healing Wounds

6/30/2023

N/A

Lidocaine for Acromioclavicular Sprain

7/1/2022

Phase 4

PRP - platelet rich plasma injection for Facet Joint Arthritis

4/1/2022

N/A

Hiatal Hernia Repair with Platelet Rich Plasma for Hiatal Hernia

10/18/2021

N/A

Treatment of GSM (platelet rich plasma) for Genitourinary Syndrome

9/23/2020

Phase 1

What Are Platelet Rich Plasma Clinical Trials?

Platelet rich plasma is a substance that can be used to promote healing in patients. It consists of two elements: plasmas, or the liquid portion of the blood, and platelets, a type of blood cell that plays a role in healing throughout the body. The term platelet rich plasma means that the blood contains more platelets than they normally do.

Platelet rich plasma is created by collecting blood samples from patients and placing them into a centrifuge system that rapidly spins the sample, separating the liquid into its components. After the components are separated into their constituents, the platelets rich plasma is injected into the target area of the patient to help with healing.

Further platelet rich plasma clinical trials are needed to discover how the technique may be used to improve healing, stimulate hair growth, address male pattern baldness, and help with various cosmetic procedures.

Why Is Platelet Rich Plasma Being Studied Through Clinical Trials?

Platelet rich plasma is playing an important role in cellular therapy and tissue engineering. Most studies indicate the beneficial impact of PRP on wound repair, angiogenesis, and differentiation. There are many applications of platelet rich plasma, such as hair growth, fat grafting, and healing acne scars.

Platelet rich plasma clinical trials can be used to study various combination therapies with carbon dioxide fractional lasers for acne scars. New methods of increasing the efficacy of PRP are also being discussed, such as adding protamine or dalteparin to improve hair density in hair transplants.

How Does Platelet Rich Plasma Treatment Work?

Scientists have not fully understood the mechanism behind platelet rich plasma. Research indicates that introducing platelet rich plasma can speed up the healing process and decrease pain. This process stimulates platelet activation by imitating the body’s natural response to injuries.

The therapy currently uses the patient's own platelets to accelerate the healing of ligaments, muscles, joints, and injured tendons.

What Are Some Recent Breakthrough Clinical Trials For Platelet Rich Plasma?

The following studies indicate progress made in Platelet Rich Plasma therapy.

2021 - PRP for Knee Osteoarthritis - This clinical trial looked at 517 patients who underwent PRP therapy for knee osteoarthritis. It found that PRP therapy is about 60% effective in managing knee osteoarthritis.

2021 - Can PRP Injections Slow Osteoarthritis? - This study looks at various clinical trials, including 1084 patients who underwent various PRP cycles. It found that PRP can help with knee osteoarthritis in patients without having to undergo total knee arthroplasty.

Who Are Some Of The Key Opinion Leaders / Researchers / Institutions Conducting Platelet Rich Plasma Trial Research?

Mikel Sánchez is widely known for his work on treating sports injuries using PRPs and received the National Award for Arts and Applied Sport Science by their Majesty King Juan Carlos and Queen Sofia. He graduated in Medical Studies from the University of Bordeaux in France and specialized in Orthopedic surgery. Sanchez is credited as the first doctor to apply PRP in the field of traumatology.

Tomas Albrektsson is a leading researcher in applied osseointegration and has also contributed to the ongoing research on the classification of platelet concentrates. He graduated from Gothenburg University and served as the Professor and Head of the Department of Biomaterials. He has conducted several lectures, and scientific papers in peer reviewed journals.

About The Author

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: August 25th, 2023

References¹ Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96. doi: 10.1016/j.joms.2003.12.003. No abstract available. https://pubmed.ncbi.nlm.nih.gov/15085519² Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96. Review. https://pubmed.ncbi.nlm.nih.gov/15085519³ Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011 Mar;3(3):226-50. doi: 10.1016/j.pmrj.2010.11.007. https://pubmed.ncbi.nlm.nih.gov/21402369⁴ Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011 Mar;3(3):226-50. doi: 10.1016/j.pmrj.2010.11.007. Review. https://pubmed.ncbi.nlm.nih.gov/21402369⁵ Wu PI, Diaz R, Borg-Stein J. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):825-853. doi: 10.1016/j.pmr.2016.06.002. Review. https://pubmed.ncbi.nlm.nih.gov/27788903⁶ Wu PI, Diaz R, Borg-Stein J. Platelet-Rich Plasma. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):825-853. doi: 10.1016/j.pmr.2016.06.002. https://pubmed.ncbi.nlm.nih.gov/27788903⁷ Petron DJ, Hanson RW Jr. Acromioclavicular joint disorders. Curr Sports Med Rep. 2007 Oct;6(5):300-6. https://pubmed.ncbi.nlm.nih.gov/17883965⁸ Park KD, Kim TK, Lee J, Lee WY, Ahn JK, Park Y. Palpation Versus Ultrasound-Guided Acromioclavicular Joint Intra-articular Corticosteroid Injections: A Retrospective Comparative Clinical Study. Pain Physician. 2015 Jul-Aug;18(4):333-41. Erratum In: Pain Physician. 2015 Sep-Oct;18(5):517. https://pubmed.ncbi.nlm.nih.gov/26218936⁹ Schneider A, Burr R, Garbis N, Salazar D. Platelet-rich plasma and the shoulder: clinical indications and outcomes. Curr Rev Musculoskelet Med. 2018 Dec;11(4):593-597. doi: 10.1007/s12178-018-9517-9. https://pubmed.ncbi.nlm.nih.gov/30196385¹⁰ Park KD, Kim TK, Lee J, Lee WY, Ahn JK, Park Y. Palpation Versus Ultrasound-Guided Acromioclavicular Joint Intra-articular Corticosteroid Injections: A Retrospective Comparative Clinical Study. Pain Physician. 2015 Jul-Aug;18(4):333-41. Erratum in: Pain Physician. 2015 Sep-Oct;18(5):517. https://pubmed.ncbi.nlm.nih.gov/26218936